Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Completed 2 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Neoplasms 19 Prostatic Neoplasms 15 Carcinoma, Non-Small-Cell Lung 15 Carcinoma, Hepatocellular 10 Urinary Bladder Neoplasms 8 Ovarian Neoplasms 8 Head and Neck Neoplasms 8 Pain 7 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Lymphoma, Follicular 6 Leukemia 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 5 Recurrence 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Non-Muscle Invasive Bladder Neoplasms 5 Brain Neoplasms 5 Small Cell Lung Carcinoma 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Leiomyoma 4 Carcinoma 4 Urologic Neoplasms 3 Urogenital Neoplasms 3 Papillomavirus Infections 3

Interventions

Radiotherapy 1 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Withdrawn × Thymoma × Clear all

NCT02633514 2026-04-27

Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

Fudan University

Phase 3 Withdrawn

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡